Hanmi to achieve remarkable growth of sales in Q1.

Published: 2006-05-08 06:56:00

Updated: 2006-05-08 06:56:00

Hanmi reported the first quarter business performances at 95,884 MW of sales, 19.0% up from the same period last year of 80,559 MW or 10.45 up from the fourth quarter of 2005, at 12,854 MW of operating income, 183.4% up from the same period last year of 4,535 MW or 18.4% up from the 4th quarter o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK